Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort
Clinical trial NCT04344782 · UNKNOWN
Trial details
- NCT number
- NCT04344782
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-15
- Primary completion
- 2020-09-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.